Saturday, September 21, 2013

Targeted failure of the week. Post No 105. RNAi delivery technology? :)

The San Diego Police Department (SDPD) said it arrested Hans Petersen, co-founder and former president and CEO of Traversa Therapeutics Inc., on Wednesday after he allegedly shot Traversa co-founder Steven Dowdy and shot at Dowdy's wife. According to a statement by the SDPD the "relationship began to sour when Petersen lost his job and blamed Dowdy." SDPD alleged Petersen also shot his brother-in-law. Both victims were hospitalized. The San Diego District Attorney's office website showed Peterson was being held without bail on charges including three counts of attempted murder.

Petersen and Dowdy co-founded Traversa in 2006 to develop an RNAi delivery technology, but the company went bankrupt. Traversa's platform grew out of research started in Dowdy's laboratory at Howard Hughes Medical Institute at the University of California San Diego in 2002. After Traversa, Dowdy co-founded Solstice Biologics LLC (San Diego, Calif.) which secured an $18 million series A round in January. Solstice is modifying nucleotide side groups in double-stranded RNAi to synthesize RiboNucleic Neutrals that are stable and not broken down in the bloodstream because they look like proteins. According to his LinkedIn page, Petersen is CEO of Bays Four (La Jolla, Calif.), which is developing a bio-repository with potential applications in law enforcement, defense, and consumer markets


From here

No comments:

Post a Comment